Silo Pharma SILO
NASDAQ SILO
$1.51 -0.10 (-6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Silo Pharma (SILO) EBITDA Margin (2020)

Updated

Silo Pharma's EBITDA Margin came in at -2673.43% for Q4 2020, up 758.52 percentage points from the prior quarter.

Analysis

Silo Pharma (SILO) EBITDA Margin (2020) Analysis & Trends

For FY2020, Silo Pharma's EBITDA Margin was -4724.96%, down 2584.09 percentage points from FY2019.

  • Going back by year, EBITDA Margin was -2140.87% in FY2019.
  • Business Quant data shows SILO's EBITDA Margin at -3431.95% (Q3 2020), -36600.54% (Q2 2020) and -26142.18% (Q1 2020) in the three quarters before Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 35.95%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 49.01%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 6.02%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 33.11%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 46.01%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 39.10%
10 Silo Pharma 1.82 Mn 1.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -2,673.43%
Sep 30, 2020 -3,431.95%
Jun 30, 2020 -36,600.54%
Mar 31, 2020 -26,142.18%
API Access

Silo Pharma EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SILO&period=max&api_key=YOUR_API_KEY